Zacks Investment Research on MSN
Denali enters into a $275M funding deal with Royalty Pharma
Denali Therapeutics Inc. DNLI has announced a funding agreement with Royalty Pharma plc RPRX for $275 million. The stock ...
Revenue: CA$18.1m (down 32% from 1H 2023). Net loss: CA$19.9m (down from CA$890.0k profit in 1H 2023). CA$1.34 loss per share (down from CA$0.06 profit in 1H 2023). You should learn about the 3 ...
TULSA, OK--(Marketwired - Nov 6, 2013) - Bayport International Holdings, Inc. (OTC Pink: BAYP) Acquisition of Royalty Interest in the Baker 1H Gas Well. Details on well are as follows: Baker 1H Gas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback